Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Covetrus Inc (CVET)

Covetrus Inc (CVET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,527,763
  • Shares Outstanding, K 111,947
  • Annual Sales, $ 3,976 M
  • Annual Income, $ -1,019,000 K
  • 60-Month Beta 2.85
  • Price/Sales 0.63
  • Price/Cash Flow 2.08
  • Price/Book 2.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.08
  • Number of Estimates 3
  • High Estimate 0.13
  • Low Estimate 0.05
  • Prior Year 0.12
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.90 +26.15%
on 07/06/20
23.16 -2.50%
on 07/31/20
+4.70 (+26.29%)
since 07/02/20
3-Month
10.45 +116.08%
on 05/15/20
23.16 -2.50%
on 07/31/20
+11.92 (+111.82%)
since 05/04/20
52-Week
4.05 +458.22%
on 03/18/20
24.38 -7.38%
on 08/07/19
-0.69 (-2.97%)
since 08/02/19

Most Recent Stories

More News
Earnings Preview: Covetrus (CVET) Q2 Earnings Expected to Decline

Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVET : 22.58 (+1.30%)
Henry Schein Reports Second Quarter 2020 Financial Results

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported second quarter 2020 financial results from continuing...

CVET : 22.58 (+1.30%)
HSIC : 69.13 (-2.50%)
NASDAQ Higher for Fifth Straight Day as Stocks Rally in Final Hour

NASDAQ Higher for Fifth Straight Day as Stocks Rally in Final Hour

SPOT : 250.02 (-1.73%)
TDOC : 249.42 (+5.18%)
UNFI : 21.28 (+4.72%)
ZS : 132.49 (-0.07%)
ACMR : 107.65 (+0.09%)
ESTC : 95.67 (-2.30%)
CRUS : 68.43 (-8.14%)
EVOP : 23.91 (+1.53%)
CMC : 21.38 (+0.33%)
SCHN : 19.10 (+1.57%)
CVET : 22.58 (+1.30%)
XOM : 43.47 (+2.89%)
UNG : 12.44 (+3.67%)
WEAT : 5.21 (-1.98%)
FVRR : 104.22 (+2.01%)
SPTN : 21.92 (+2.19%)
DSPG : 15.63 (+1.82%)
ALNY : 152.76 (+0.30%)
AVXL : 4.80 (+8.60%)
EDIT : 31.88 (+0.98%)
Covetrus Announces Chief Product Officer for Global Technology Solutions

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, has named Arman Samani to the role of chief product officer (CPO). Arman will be responsible for developing and driving...

TSCC : 0.0300 (+114.29%)
CVET : 22.58 (+1.30%)
First Week of July 17th Options Trading For Covetrus (CVET)

Investors in Covetrus Inc saw new options begin trading this week, for the July 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CVET options chain for the...

CVET : 22.58 (+1.30%)
A Familiar Foe Awakens

A Familiar Foe Awakens

SCO : 15.97 (-2.98%)
NICE : 208.04 (+2.82%)
MRNA : 78.46 (+0.62%)
AVID : 9.25 (+9.99%)
AKTS : 8.05 (+0.69%)
ACB : 10.73 (+2.98%)
CVET : 22.58 (+1.30%)
VSAT : 38.34 (+2.24%)
Covetrus' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Covetrus.

CVET : 22.58 (+1.30%)
Covetrus (CVET) Q1 Earnings and Revenues Miss Estimates

Covetrus (CVET) delivered earnings and revenue surprises of -5.56% and -0.27%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CVET : 22.58 (+1.30%)
Covetrus: 1Q Earnings Snapshot

PORTLAND, Maine (AP) _ Covetrus Inc. (CVET) on Thursday reported a loss of $33 million in its first quarter.

CVET : 22.58 (+1.30%)
Another Day of Losses as Market’s Mood Sours

Another Day of Losses as Market’s Mood Sours

CVET : 22.58 (+1.30%)
BNFT : 12.34 (+3.18%)
UVXY : 23.77 (-4.35%)
SDOW : 20.95 (-1.97%)
PLNT : 53.64 (+5.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CVET with:

Business Summary

Covetrus, Inc. provides animal-health technology and services. The Company combines practice management software, prescription management, multi-channel client engagement services and supply chain infrastructure to promote connectivity between veterinarians and their clients. Covetrus, Inc. is based...

See More

Key Turning Points

2nd Resistance Point 23.51
1st Resistance Point 23.05
Last Price 22.58
1st Support Level 21.86
2nd Support Level 21.14

See More

52-Week High 24.38
Last Price 22.58
Fibonacci 61.8% 16.61
Fibonacci 50% 14.21
Fibonacci 38.2% 11.81
52-Week Low 4.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar